Outcome of Frail Do-Not-Intubate Subjects With End-Stage Chronic Respiratory Failure and Their Opinion of Noninvasive Ventilation to Reverse Hypercapnic Coma.

Authors:
Malcolm Lemyze
Malcolm Lemyze
Schaffner Hospital
France
Aurelie Guiot
Aurelie Guiot
University of Michigan
Quentin Bury
Quentin Bury
Béthune Beuvry Hospital
Beuvry | France
Marie Jonard
Marie Jonard
Centre Hospitalier du Dr. Schaffner
Lens | France
Didier Thevenin
Didier Thevenin
Schaffner Hospital
France
Jihad Mallat
Jihad Mallat
Schaffner Hospital
France

Respir Care 2019 Mar 19. Epub 2019 Mar 19.

Department of Respiratory and Critical Care Medicine, Schaffner Hospital, Lens, France.

Background: The use of noninvasive ventilation (NIV) in the emergency setting to reverse hypercapnic coma in frail patients with end-stage chronic respiratory failure and do-not-intubate orders remains a questionable issue given the poor outcome of this vulnerable population. We aimed to answer this issue by assessing not only subjects' outcome with NIV but also subjects' point of view regarding NIV for this indication.

Methods: A prospective observational case-control study was conducted in 3 French tertiary care hospitals during a 2-y period. Forty-three individuals who were comatose (with pH < 7.25 and > 100 mm Hg at admission) were compared with 43 subjects who were not comatose and who were treated with NIV for acute hypercapnic respiratory failure. NIV was applied by using the same protocol in both groups. They all had a do-not-intubate order and were considered vulnerable individuals with end-stage chronic respiratory failure according to well-validated scores.

Results: NIV yielded similar outcomes in the 2 groups regarding in-hospital mortality ( = 12 [28%] vs = 12 [28%] in the noncomatose controls, > .99) and 6-month survival ( = 28 [65%] vs = 22 [51%] in the noncomatose controls, = .31). Despite poor quality of life scores (21.5 ± 10 vs 31 ± 6 in the awakened controls, = .056) as assessed by using the VQ11 questionnaire 6 months to 1 y after hospital discharge, a large majority of the survivors ( = 23 [85%]) would be willing to receive NIV again if a new episode of acute hypercapnic respiratory failure occurs.

Conclusion: In the frailest subjects with supposed end-stage chronic respiratory failure that justifies treatment limitation decisions, it is worth trying NIV when acute hypercapnic respiratory failure occurs, even in the case of extreme respiratory acidosis with hypercapnic coma at admission.

Download full-text PDF

Source
http://dx.doi.org/10.4187/respcare.06346DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
March 2019
8 Reads

Publication Analysis

Top Keywords

respiratory failure
28
end-stage chronic
16
chronic respiratory
16
hypercapnic coma
12
acute hypercapnic
12
hypercapnic respiratory
12
noninvasive ventilation
8
niv
8
noncomatose controls
8
reverse hypercapnic
8
niv acute
8
respiratory
8
failure
7
hypercapnic
6
failure niv
4
niv applied
4
frail do-not-intubate
4
comatose treated
4
subjects comatose
4
niv episode
4

Similar Publications